Rheumatology and Therapy

Rheumatology and Therapy is published by Springer Healthcare and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Rheumatoid Arthritis Research and Therapies, Spondyloarthritis Studies and Treatments and Psoriasis: Treatment and Pathogenesis, together about 59.8% of its articles. Its main subfields are Rheumatology. (generated from OpenAlex topic counts and CAS ranking data)

Aims and ScopeRheumatology and Therapy is an international, open access, peer reviewed, rapid publication journal dedicated to the publication of high-quality clinical (all phases), observational, real-world and health outcomes research around the discovery, development, and use of rheumatologic therapies. Studies relating to diagnosis, pharmacoeconomics, public health, quality of life, and patient care, management, and education are also welcomed. Areas of focus include, but are not limited to, rheumatoid arthritis, gout, gouty arthritis, psoriatic arthritis, osteoarthritis, juvenile idiopathic/rheumatoid arthritis, systemic lupus erythematosus, axial spondyloarthritis, Pompe’s disease, inflammatory joint conditions, musculoskeletal conditions, systemic sclerosis, and fibromyalgia. The journal is of interest to a broad audience of healthcare professionals and publishes original research, reviews, case reports, trial protocols, communications and letters. The journal is read by a global audience and receives submissions from all over the world. Rheumatology and Therapy will consider all scientifically sound research be it positive, confirmatory or negative data. Submissions are welcomed whether they relate to an international and/or a country-specific audience, something that is crucially important when researchers are trying to target more specific patient populations. This inclusive approach allows the journal to assist in the dissemination of all scientifically and ethically sound research. Ethics and DisclosuresThe journal is a member of the Committee on Publication Ethics (COPE) and subscribes to its principles on how to deal with acts of misconduct thereby committing to investigate allegations of misconduct in order to ensure the integrity of research. Content in this journal is peer-reviewed (Single-blind). For more information on our publishing ethics policies, please see here: https://www.springer.com/gp/editorial-policiesRapid Publication The journal aims for a 2-week peer review, and 3-4 weeks from acceptance to online. Please note that for any steps outside of our standard publication processes, such as multiple rounds of peer review or article proofs, or non-standard copyright requests, this may delay publication beyond these timelines. Personal ServiceThe journal’s dedicated in-house editorial team offer a personal “concierge service” meaning that authors will always have a personal point of contact able to update them on the status of their

From the journal's Aims & Scope

Research area (LetPub): RHEUMATOLOGY

Editor-in-chief Roy FleischmannPublisher website

Editorial board by country: 2 in mainland China (about 2%); most named United States 17, Italy 12, Japan 9, United Kingdom 5, France 4 (84 members with a country) Editorial board ↗Publisher website · 2026-09-29

CAS Journal Ranking

Database indexing

SCIEScopusDOAJLetPub

International journal early-warning lists: not listed in any editionLetPub

Indexing the journal's website claims

EmbaseCurrent ContentsPublisher website

Other: Google Scholar, EBSCO, ProQuest, Dimensions, CNKI, Baidu, Naver, OCLC, Portico, CLOCKSS, Semantic Scholar

As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Impact

Impact factor

3.09LetPub · 2026-09-13

Impact factor (publisher) 2025

3.1Publisher website · 2026-09-29

5-year impact factor (publisher) 2025

3.6Publisher website · 2026-09-29

CiteScore 2026-06

5.9LetPub · 2026-09-13

SJR 2026-06

0.99LetPub · 2026-09-13

SNIP 2026-06

0.97LetPub · 2026-09-13

h-index

54OpenAlex · 2026-10-01

i10-index

393OpenAlex · 2026-10-01

2-year mean citedness

3.46OpenAlex · 2026-10-01

Self-citation rate

9.7%LetPub · 2026-09-13

Share of gold OA articles

100%LetPub · 2026-09-13

Volume

Articles per year

73LetPub · 2026-09-13

Downloads per year (publisher) 2025

759,100Publisher website · 2026-09-29

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Other sources

Average review time (community reports)

about 6 weeksLetPub · 2026-09-13

Submission to first decision

4 daysPublisher website · 2026-09-29

Acceptance to publication

28 daysPublisher website · 2026-09-29

Submission to publication (journal-reported)

about 6 weeksDOAJ · 2026-10-25

Peer review

Single anonymous peer reviewDOAJ

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

• APC information ↗DOAJ
• Fee waivers ↗DOAJ
• Open access statement ↗DOAJ
• License & copyright ↗DOAJ

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.

Publisher

Springer Healthcare

Country or region

ENGLAND

Language

English

Frequency

6 issues per year

Founded

2014

ISSN

2198-6576

Electronic ISSN

2198-6584

Latest issue on the website

Volume 13, Issue 4 (August 2026)

Official links

• Journal homepage ↗DOAJ
• Submission system ↗LetPub
• Author guidelines ↗LetPub
• Aims & Scope ↗LetPub
• Special issues ↗Publisher website
• APC information ↗DOAJ
• Fee waivers ↗DOAJ
• Open access statement ↗DOAJ
• License & copyright ↗DOAJ
• Peer review process ↗LetPub
• Editorial board ↗LetPub
• Plagiarism policy ↗DOAJ